Connect your AI

Capricor Therapeutics CAPR Price / sales

Price / sales at other companies

PfizerPFE

2.5×+0.2×

Sarepta Therapeutics, Inc.SRPT

1×—

PTC TherapeuticsPTCT

6.8×+4.6×

Celldex TherapeuticsCLDX

2,438.2×+2,279×

VericelVCEL

5.6×-3.8×

Viridian Therapeutics, Inc.VRDN

28.2×-3,609×

Other financials

Income statement

Revenue--100%

Operating income-$36.8M-47.2%

Net income-$33.9M-39.2%

EPS (diluted)-$0.59-11.3%

Balance sheet

Cash & equivalents$105.4M+266%

Total debt$14.8M+1,083%

Total equity$278.7M+118%

Total assets$326.3M+112%

Cash flow

Operating cash flow-$29.3M-355%

CapEx$5.1M+472%

Free cash flow-$34.4M-369%

Valuation

Market cap$1.71B+303%

Enterprise value$1.62B+308%

Profitability

Operating margin-778.8%-1,038pp

Net margin-736.6%-981pp

FCF margin-563.9%-954pp

Returns & leverage

Return on equity-56.4%-11.3pp

Debt / equity0.1×0.0×

Current ratio8.4×+1.9×

Where this comes from

Calculated from Capricor Therapeutics’s reported figures.

market cap/total revenue=29.6×

Based on the most recent quarter.

The official record: Capricor Therapeutics’s 10-Q, filed November 10, 2025, on SEC EDGAR. View the filing →

Ask your AI about Capricor Therapeutics's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Capricor Therapeutics's price / sales?: Capricor Therapeutics (CAPR) reported price / sales of 29.6× in Q3 2025.
How has Capricor Therapeutics's price / sales changed year-over-year?: Capricor Therapeutics's price / sales increased by 28.0% year-over-year, from 23.1× to 29.6×.
What is the long-term trend for Capricor Therapeutics's price / sales?: Over 2 years (2020 to 2024), Capricor Therapeutics's price / sales has grown at a -67.5% compound annual growth rate (CAGR), from 267× to 28.2×.
What does price / sales mean?: Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.